DataMeds AI
MEDS
9 hedge funds and large institutions have $161K invested in DataMeds AI in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 9 closing their positions.
0.03% more ownership
Funds ownership: 2.03% → 2.06% (+0.03%)
22% less capital invested
Capital invested by funds: $205K → $161K (-$44.7K)
31% less funds holding
Funds holding: 13 → 9 (-4)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$91.7K |
| 2 |
Barclays
London,
United Kingdom
|
+$3.56K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.33K |
| 4 |
FFO
Fortitude Family Office
Scottsdale,
Arizona
|
+$580 |
| 5 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$12K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$8.6K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$7.14K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$5.63K |
| 5 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$4.92K |
MEDS Hedge Fund Activity: Q2 2026 in Review
9 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in DataMeds AI (MEDS) for Q2 2026, worth a combined $161K — down 22% from $205K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of MEDS and 5 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $91.7K. The largest seller was State Street, exiting entirely with an estimated $12K sold.
- 9 institutional investors held DataMeds AI (MEDS) as of Q2 2026, down from 13 in Q1 2026.
- Funds reported $161K of DataMeds AI stock for Q2 2026, down 22% quarter-over-quarter.
- 5 funds opened new DataMeds AI positions in Q2 2026 and 9 closed out, a net change of -4 holders.
- The largest DataMeds AI buyer in Q2 2026 was Jane Street, an estimated $91.7K added.
- The largest DataMeds AI seller in Q2 2026 was State Street, an estimated $12K sold.
Based on aggregated 13F filings for Q2 2026.